We are live on
!
Find out more
ICM
Invenomic Capital Management Portfolio holdings
AUM
$2.18B
1-Year Est. Return
0.03%
This Fund
S&P 500
This Quarter
Est. Return
+5.36%
1 Year Est. Return
+0.03%
3 Year Est. Return
-6.37%
5 Year Est. Return
-25.27%
10 Year Est. Return
–
AUM
$1.47B
AUM Growth
+$309M
(+27%)
Cap. Flow
+$259M
Cap. Flow
% of AUM
17.55%
Top 10 Holdings %
Top 10 Hldgs %
27.29%
Holding
179
New
33
Increased
51
Reduced
54
Closed
39
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Applovin
APP
|
+$58.8M |
| 2 |
Lyft
LYFT
|
+$27.4M |
| 3 |
Clarivate
CLVT
|
+$26.3M |
| 4 |
Frontdoor
FTDR
|
+$24.5M |
| 5 |
Salesforce
CRM
|
+$23.3M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Cisco
CSCO
|
+$27.1M |
| 2 |
Universal Health Services
UHS
|
+$22.3M |
| 3 |
POSH
Poshmark, Inc. Class A Common Stock
POSH
|
+$21M |
| 4 |
Cabot Corp
CBT
|
+$18.2M |
| 5 |
CIVI
Civitas Resources
CIVI
|
+$17.7M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 31.82% |
| 2 | Consumer Discretionary | 14.98% |
| 3 | Communication Services | 13.53% |
| 4 | Healthcare | 8.23% |
| 5 | Industrials | 8.05% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
LUXE
126
LuxExperience B.V.
LUXE
$1.11B
| $1.54M | 0.1% |
+173,025
| New | +$1.78M |
|
|
127
Cabot Corp
CBT
$4.46B
| $1.41M | 0.1% |
21,168
-261,236
| -93% | -$18.2M |
|
|
PHX
128
DELISTED
PHX Minerals
PHX
| $1.31M | 0.09% |
336,118
-19,853
| -6% | -$74.5K |
|
129
DXP Enterprises
DXPE
$2.99B
| $1.26M | 0.09% |
45,749
-2,427
| -5% | -$64.5K |
|
130
Red Robin
RRGB
$150M
| $1.23M | 0.08% |
220,886
-11,787
| -5% | -$87.8K |
|
131
Lexaria Bioscience
LEXX
$9.07M
| $1.16M | 0.08% |
31,540
| – | – |
|
132
Algoma Steel
ASTL
$468M
| $1.13M | 0.08% |
+178,248
| New | +$1.17M |
|
133
LendingTree
TREE
$453M
| $1.13M | 0.08% |
+52,843
| New | +$1.2M |
|
134
Energy Transfer Partners
ET
$70.9B
| $1.09M | 0.07% |
92,211
-334,590
| -78% | -$4.01M |
|
135
STRATTEC Security
STRT
$349M
| $866K | 0.06% |
42,123
+1,424
| +3% | +$34.9K |
|
|
MAGN
136
Magnera Corp
MAGN
$466M
| $803K | 0.05% |
22,221
-1,157
| -5% | -$47.2K |
|
137
Arlo Technologies
ARLO
$1.6B
| $750K | 0.05% |
+213,637
| New | +$879K |
|
138
Cellebrite
CLBT
$3.97B
| $655K | 0.04% |
+150,308
| New | +$671K |
|
|
ILLM
139
DELISTED
illumin Holdings Inc. Common Shares
ILLM
| $289K | 0.02% |
187,636
-599,848
| -76% | -$987K |
|
|
CVT
140
DELISTED
Cvent Holding Corp. Common Stock
CVT
| $228K | 0.02% |
42,186
-2,372
| -5% | -$13.1K |
|
141
Adeia
ADEA
$3.07B
| – | – |
-1,689,482
| Closed | -$6.32M |
|
142
Anika Therapeutics
ANIK
$277M
| – | – |
-140,312
| Closed | -$3.34M |
|
|
CVSA
143
Covista Inc
CVSA
$4.38B
| – | – |
-152,539
| Closed | -$5.56M |
|
144
Belden
BDC
$5.28B
| – | – |
-117,440
| Closed | -$7.05M |
|
145
Coca-Cola Europacific Partners
CCEP
$46.9B
| – | – |
-111,407
| Closed | -$4.75M |
|
|
146
Cisco
CSCO
$483B
| – | – |
-678,338
| Closed | -$27.1M |
|
|
DHIL
147
DELISTED
Diamond Hill
DHIL
| – | – |
-9,388
| Closed | -$1.55M |
|
|
EHAB
148
DELISTED
Enhabit
EHAB
| – | – |
-203,440
| Closed | -$2.86M |
|
149
GoDaddy
GDDY
$11.6B
| – | – |
-70,229
| Closed | -$4.98M |
|
150
Howard Hughes
HHH
$3.91B
| – | – |
-79,474
| Closed | -$4.2M |
|
Similar funds
SIG
ORCP
ET
GC
MIAS
TAL
IIP
WCMNY
Invenomic Capital Management's Q4 2022 Portfolio in Review
As of Q4 2022, Invenomic Capital Management held 179 positions worth $1.47B, up 27% from $1.16B the previous quarter. Its ten largest holdings account for 27% of the portfolio.
Invenomic Capital Management deployed $259M of net new capital in Q4 2022, opening 33 new positions and adding to 51 existing holdings. Its largest new stake was Clarivate: 2,805,166 shares worth $23.4M.
By sector, the portfolio is most concentrated in Technology at 32% of assets, up from 30% a quarter earlier, followed by Consumer Discretionary and Communication Services.
On the sell side, the largest reduction was Universal Health Services, an estimated $22.3M trimmed.
- Invenomic Capital Management's largest Q4 2022 buy was Clarivate: 2,805,166 shares worth $23.4M.
- Invenomic Capital Management added most to Applovin in Q4 2022, an estimated $58.8M increase.
- Invenomic Capital Management's biggest Q4 2022 reduction was Universal Health Services, cutting an estimated $22.3M.
- Invenomic Capital Management fully exited Cisco in Q4 2022, selling an estimated $27.1M.
- Invenomic Capital Management's ten largest holdings make up 27% of its $1.47B portfolio in Q4 2022.
- Invenomic Capital Management opened 33 new positions and closed 39 in Q4 2022.
- Invenomic Capital Management's portfolio value rose 27% quarter-over-quarter to $1.47B.
Based on Invenomic Capital Management's 13F filing for Q4 2022, filed 14 Feb 2023.